TECTONIC THERAPEUTIC, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 10.63K shares, a 95.46% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 60.59K shares, a 84.97% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 71.22K shares, a 34.79% increase from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 52.83K shares, a 82.25% decline from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 297.60K shares, a 109.56% increase from fiscal 2022.
- TECTONIC THERAPEUTIC, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 142.01K shares, a 37.21% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 71.22K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -152.81K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 10.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -142.66K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 60.59K shares 10-Q · filed 2025-05-08 | 80.67K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | -224.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 52.83K shares 10-K · filed 2025-03-20 |
| 2024-09-30 | 10.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 351.19K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 233.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 447.72K shares derived: sum of 4 quarters · filed 2024-08-14 |
| 2024-03-31 | 32.76K shares 10-Q · filed 2024-05-09 | 284.36K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 74.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 297.60K shares 10-K · filed 2024-03-14 |
| 2023-09-30 | 106.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 365.29K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 70.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 258.60K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | 46.00K shares 10-Q · filed 2023-05-11 | 188.01K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | 142.01K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 142.01K shares 10-K · filed 2023-03-23 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 20.21K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 29.31K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-11 | 29.31K shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 20.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 226.18K shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 9.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 314.55K shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 312.23K shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 196.87K shares 10-Q · filed 2021-05-13 | 336.77K shares derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-12-31 | 108.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 147.34K shares 10-K · filed 2021-03-18 |
| 2020-09-30 | 6.78K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 42.49K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 24.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 41.31K shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | 7.44K shares 10-Q · filed 2020-05-07 | 127.06K shares derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | 3.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 236.48K shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 5.61K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 249.73K shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 110.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 244.12K shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | 116.86K shares 10-Q · filed 2019-05-13 | |
| 2018-12-31 | 16.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | 16.97K shares 10-K · filed 2019-03-25 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |